Lanean...
Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin
BACKGROUND AND PURPOSE: In randomized trials, atrial fibrillation (AF) patients receiving dabigatran, a direct oral anticoagulant, had lower risk of intracranial bleeding (ICB) than those on warfarin. However, concerns exist about potential worse outcomes in dabigatran users if bleeding occurs, give...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4116615/ https://ncbi.nlm.nih.gov/pubmed/24994722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.114.006016 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|